AdamsonJones, a firm of patent and trade mark attorneys, has helped more Nottinghamshire companies protect their inventions overseas through the World Intellectual Property Office (WIPO) than any other rival firm of patent attorneys in the county. Statistics from WIPO show that since 2015 AdamsonJones, which has...
Mironid is delighted to announce the appointment of Dr Steve Felstead as Chief Medical Officer (CMO) Dr Felstead retired from the position of Vice President, Head of Clinical Research, Pharmatherapeutics Division, Pfizer Inc in April 2014. He joined Pfizer in 1989, having qualified in Medicine at Leeds...
London and Manchester, UK, New York, NY and Oslo, Norway: 27, March 2018: Confirmit and 7i Group Ltd, a specialist healthcare consultancy, have formed a strategic collaboration to harness their Market Research and pharmaceutical sector knowledge and expertise. The collaboration will enable an enhanced patient-centric...
APPLICATIONS ARE NOW OPEN – DEADLINE 2 MAY The Unlocking Ambition Challenge will invest in a group of up to 20 early stage entrepreneurs who will be chosen, mentored and led by some of Scotland’s leading entrepreneurs. They’re looking for early-stage, high-potential entrepreneurs, innovators, academics and...
The finalists for this year’s Scottish SME Business Awards have been announced after nominations surged in from across Scotland. The awards not only provide a platform and an opportunity to recognise and reward the talented individuals and organisations from the SME industry but also provide a...
Funding will enable BDD to scale up GMP manufacture of revolutionary time controlled “pill within a pill”. Archangels, the Edinburgh-based business angel syndicate, the Scottish Investment Bank, the investment arm of Scotland’s enterprise agencies, and Bio-Images Drug Delivery Limited (BDD) announce the completion of a £2m...
Asynt reports that medicinal chemistry specialists Charnwood Molecular have been using the DrySyn MAXI heating system to successfully and reproducibly scale up syntheses within their contract research laboratories. Dr Michael McKenzie, Head of Operations, said: “Here at Charnwood Molecular our experienced preclinical R&D team routinely investigate...
A two-year-long discovery chemistry collaboration between Charnwood Molecular and Forendo Pharma has seen compounds move from discovery to pre-clinical development. Charnwood Molecular and Forendo Pharma have been collaborating since September 2015, with Charnwood Molecular synthesising challenging steroidal analogues of a hit compound initially identified at Forendo...
Upperton Pharma Solutions is pleased to announce that the company has relocated to larger, self-contained facilities at Highfields Science Park, adjacent to the University of Nottingham. The move to new premises underlines the company’s rapid expansion and will enable it to develop its own cGMP...